1 – 20 of 32
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
(
- Contribution to journal › Article
- 2019
-
Mark
Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
The serotonergic system in L-DOPA-induced dyskinesia : pre-clinical evidence and clinical perspective
(
- Contribution to journal › Article
-
Mark
On the neuronal circuitry mediating l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
(
- Contribution to journal › Article
- 2015
-
Mark
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)
(
- Contribution to journal › Article
- 2013
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
- 2012
-
Mark
Monte Carlo feature selection and rule-based models to predict Alzheimer's disease in mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease
(
- Contribution to journal › Article
- 2011
-
Mark
Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?
(
- Contribution to journal › Article
-
Mark
TAR-DNA binding protein-43 and alterations in the hippocampus
(
- Contribution to journal › Article
- 2010
-
Mark
Association of the RAGE G82S polymorphism with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid insulin during non-neurological surgery
(
- Contribution to journal › Article
-
Mark
Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off : efficacy, safety and feasibility--an open-label, 6-week study
(
- Contribution to journal › Article
- 2008
-
Mark
Non-neurological surgery results in a neurochemical stress response
(
- Contribution to journal › Letter
- 2006
-
Mark
Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment
(
- Contribution to journal › Article
- 2005
-
Mark
The European Multiple System Atrophy-Study Group (EMSA-SG)
(
- Contribution to journal › Article